title:: Cleerly uses AI-driven heart imaging technology to help save lives with AWS
publisher:: AWS
people:: Jim Min, Razvan Ionasec
domain:: Healthcare, Artificial Intelligence, Medical Imaging, Cloud Computing
Summary
Cleerly, a digital health company, has developed AI-powered solutions, Cleerly Coronary and Cleerly Labs, to provide comprehensive, quantitative assessment of coronary artery disease (CAD) using non-invasive coronary computed tomography angiograms (CCTAs). Cleerly leverages AWS’ cloud infrastructure, including Amazon EC2 GPU instances, AWS Batch, Amazon SQS, Amazon ECS, AWS CodeBuild, and AWS CodeDeploy, to deliver these clinical insights at scale with rapid turnaround times. Cleerly’s AI algorithms quantify atherosclerotic plaque characteristics and vascular morphology from CCTA data, enabling clinicians to identify key features linked to heart attack risk. By using AWS, Cleerly can focus on innovation, scale efficiently, and ensure data security and recoverability.
Data Points
- Cleerly developed Cleerly Coronary and Cleerly Labs for AI-driven coronary artery disease assessment
- Uses non-invasive CCTAs and ML algorithms to quantify plaque and vascular features
- Shown to reduce heart attack risk by 41% in symptomatic patients with suspected CAD
- Leverages AWS for scalable infrastructure: Amazon EC2 P3 instances, AWS Batch, Amazon SQS, Amazon ECS, AWS CodeBuild, AWS CodeDeploy, Amazon CloudFront
- AWS enables rapid innovation, efficient scaling, data security, and disaster recovery
- Cleerly built platform on AWS from start to focus on product instead of infrastructure management
- Uses AWS spot instances and reserved instances for cost optimization
- Ensures HIPAA compliance and end-to-end encryption with AWS security capabilities
- Allows rapid experimentation with new algorithms and ML models by data science team